human embryonic stem cell-based therapy (Jeil)

N/A

Report date: 2025/01/26 19:32:48

Base Information

Drug Namehuman embryonic stem cell-based therapy (Jeil)

Drug Alias NamehESC-based therapy (Jeil)

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Neurogenic potential stem cell therapy

Mechanisms of ActionStem cells stimulants

TargetsUpdating

Therapy Area/IndicationsMacular DegenerationParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesJeil Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesJeil Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsMacular DegenerationParkinson Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A